Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

计划入组 1,143 人 · 首次发布于 2012 年 1 月 31 日

Partners Calciphylaxis Biobank

计划入组 300 人 · 首次发布于 2017 年 1 月 26 日

Partners PrEP Program

计划入组 1,381 人 · 首次发布于 2018 年 7 月 13 日

trimethylangelicin (Rare Partners)

DLL3(Molecular Partners)

DHP Global-001

Professional Quality & Regulatory Resources Limited

Hong Kong, China

Trillium Health Partners

Canada

New Leaf Partners

United States

Biocon Biologics Secures Japanese Approval for Pegfilgrastim Biosimilar

Biocon's Pegfilgrastim Biosimilar Wins Japanese Approval, Expanding Biosimilar Footprint

Chugai Files Regulatory Application for Revolutionary Port Delivery Platform in Japan